AlphAIAlphAI — Financial news for AI agents
tipranks.com$HUM

Humana Reports Third-Quarter Earnings and Business Growth

Humana (HUM) reported Q3 GAAP EPS of $1.33 and adjusted loss of $0.70, with YTD GAAP and adjusted EPS at $16.84 and $17.17. The company saw growth in CenterWell patients and Medicaid membership. Analysts rate HUM as a Buy with a $425 target, but Spark's AI rates it Neutral due to mixed fundamentals and valuation concerns.

Original reporting
tipranks.com
Published Nov 6, 2026, 11:51 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 6, 2026, 12:14 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About AlphAI AI DeskScoring methodologyReport an issue
AlphAI market briefEarnings
Primary signal
$HUM
Bearish
high confidence
Mentioned
$HUM
Relevance
8/10
AlphAI data visualization · based on tipranks.com
Decision brief

The 30-second read

$HUMBearishMed
01

Why it matters

The adjusted loss signals margin pressure, but strong enrollment growth may support future earnings.

02

Market read

Earnings miss could trigger short‑term price pressure; investors will watch cost‑control measures and enrollment trends.

03

What to watch

Potential upside from cost‑reduction initiatives and Medicaid enrollment gains.

Relevance 8/10Novelty 8/10Timing: today

Background

Humana is a major U.S. health insurer with a market cap of $50B, reporting its third‑quarter results.

Company-level read

Ticker impact

$HUMBearishHigh confidence
Context

Humana disclosed its Q3 GAAP EPS of $1.33 and an adjusted loss of $0.70 per share, plus membership growth figures, in a fresh earnings release.

Expected impact

likely modest downside as the market prices in the adjusted loss

Evidence & confidence

The earnings numbers are the first public disclosure and show a surprise loss, which typically triggers short-term selling pressure.

Market effects

Sector

Health insurance sector may see broader scrutiny as earnings miss highlights cost pressures.

Regional

U.S. healthcare stocks could experience slight pullback.

Global

Limited to U.S. markets; no immediate global ripple.

Counterpoint

What could challenge this read

Membership growth and new BlackRock JV could offset earnings weakness over the longer term.

Key entities

  • company
    Humana

    U.S. health insurer reporting Q3 results.

Read at source← All news

StoryHumana posts Q3 2026 results and lifts FY2026 adjusted EPS guidance to at least $9.50

Also covered by

6 outlets

Related articles

$HUMHighAI 8/10

Humana Raises Profit Floor on Lower Costs

Humana (HUM) raised its 2026 adjusted earnings guidance to at least $9.50 per share from $9.00, citing lower costs. Q3 insurance benefit ratio was 93.7%, better than expected. Shares fell 0.59% in pre-market trading. Humana's Medicare Advantage membership grew 23% this year.

asktraders.com
$HUMHighAI 8/10

HUM Q3 FY2026 earnings call

Humana Inc. reported Q3 2026 earnings exceeding expectations, raising full-year adjusted EPS guidance to at least $9.50. The company cited favorable medical cost trends and strong execution. Management highlighted progress in clinical quality, Medicaid expansion, and capital allocation, including a divestiture and a new joint venture. Humana expects 2027 Medicare Advantage membership growth and an 8%-9% medical cost trend, with risks and opportunities outlined.

finance.biggo.com
$HUMHighAI 8/10

[Humana Q3 2026 Earnings Call] Humana Lifts Full-Year EPS Guidance to at Least $9.50 as Medical Cost Trend Lands at Low End of 7%-8% Range

Humana Inc. raised its full-year 2026 adjusted EPS guidance to at least $9.50 per share from $9.00, citing favorable medical cost trends. The company reported strong STARS performance and plans to use excess funds for investments and shareholder returns. Humana also announced balance sheet improvements through divestitures and a new joint venture with BlackRock. Management expects 2027 Medicare Advantage membership growth and higher medical cost trends.

finance.biggo.com
$HUMMed

Humana Lifted Its Profit Forecast As Medical Costs Cooled

Humana raised its profit forecast due to lower medical costs, despite posting an adjusted quarterly loss. The company reported a 93.7% medical cost ratio, which may influence its Medicare Advantage pricing. Humana's individual Medicare Advantage membership grew 23% year-to-date, with a target of 25% growth by 2026 and a pretax margin of at least 3% by 2028.

finimize.com